Medicine
Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
Cohort study of 126 peopleInterventions
8 weeks
- Dapagliflozin + semaglutide
- Inflammation
- Type 2 diabetes
- Chronic kidney disease
- Blood urea nitrogen
- Humans
The paper
Yangtze River Shipping General Hospital
Medicine, 9 Oct 2026
